Latest / Texas News Today | 2 Min News | The Daily News Now!
FDA Approves First Disease-Modifying Alzheimer’s Drug | Texas News
FDA just approved Leqembi, the first drug in years to target Alzheimer’s root cause—amyloid plaques—slowing cognitive decline in early-stage patients. After initial accelerated approval based on plaque reduction, full approval now rests on strong trial data showing modest but meaningful disease slowing over 18 months. While not a cure, it offers families a vital window of time and hope. But caution is key: serious side effects like brain swelling or bleeding require close monitoring. This breakthrough marks a pivotal shift from symptom management to tackling Alzheimer’s biology—opening the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.